Three patients with homozygous familial hypercholesterolemia: Genomic sequencing and kindred analysis

被引:3
|
作者
Wong, Karen H. Y. [1 ]
Levy-Sakin, Michal [1 ]
Ma, Waifred [1 ]
Gonzaludo, Nina [1 ]
Mak, Angel C. Y. [1 ,2 ]
Vaka, Dedeem A. [3 ]
Poon, Annie [3 ]
Chu, Catherine [3 ]
Lao, Richard [3 ]
Balamir, Melek [4 ]
Grenville, Zoe [1 ]
Wong, Nicolas [1 ]
Kane, John P. [1 ,5 ,6 ]
Kwok, Pui-Yan [1 ,3 ,7 ]
Malloy, Mary J. [1 ,5 ,8 ]
Pullinger, Clive R. [1 ,9 ]
机构
[1] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA
[4] Istanbul Univ, Dept Internal Med, Istanbul, Turkey
[5] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[6] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA
[7] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA
[8] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
[9] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA 94143 USA
来源
MOLECULAR GENETICS & GENOMIC MEDICINE | 2019年 / 7卷 / 12期
基金
美国国家卫生研究院;
关键词
10xG linked-reads whole genome sequencing; dyslipidemia; LDL; whole exome sequencing; DENSITY-LIPOPROTEIN CHOLESTEROL; LDL RECEPTOR GENE; MUTATIONS; IDENTIFICATION; POPULATION; PREVALENCE; VARIANTS; PLASMA; INDIVIDUALS; DISEASE;
D O I
10.1002/mgg3.1007
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Homozygous Familial Hypercholesterolemia (HoFH) is an inherited recessive condition associated with extremely high levels of low-density lipoprotein (LDL) cholesterol in affected individuals. It is usually caused by homozygous or compound heterozygous functional mutations in the LDL receptor (LDLR). A number of mutations causing FH have been reported in literature and such genetic heterogeneity presents great challenges for disease diagnosis. Objective We aim to determine the likely genetic defects responsible for three cases of pediatric HoFH in two kindreds. Methods We applied whole exome sequencing (WES) on the two probands to determine the likely functional variants among candidate FH genes. We additionally applied 10x Genomics (10xG) Linked-Reads whole genome sequencing (WGS) on one of the kindreds to identify potentially deleterious structural variants (SVs) underlying HoFH. A PCR-based screening assay was also established to detect the LDLR structural variant in a cohort of 641 patients with elevated LDL. Results In the Caucasian kindred, the FH homozygosity can be attributed to two compound heterozygous LDLR damaging variants, an exon 12 p.G592E missense mutation and a novel 3kb exon 1 deletion. By analyzing the 10xG phased data, we ascertained that this deletion allele was most likely to have originated from a Russian ancestor. In the Mexican kindred, the strikingly elevated LDL cholesterol level can be attributed to a homozygous frameshift LDLR variant p.E113fs. Conclusions While the application of WES can provide a cost-effective way of identifying the genetic causes of FH, it often lacks sensitivity for detecting structural variants. Our finding of the LDLR exon 1 deletion highlights the broader utility of Linked-Read WGS in detecting SVs in the clinical setting, especially when HoFH patients remain undiagnosed after WES.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Homozygous familial hypercholesterolemia: Summarized case reports
    Widhalm, Kurt
    Benke, Ina Michel
    Fritz, Michael
    Geiger, Harald
    Helk, Oliver
    Fritsch, Maria
    Hoermann, Gregor
    Kostner, Gerhard
    ATHEROSCLEROSIS, 2017, 257 : 86 - 89
  • [22] Targeted Next-Generation Sequencing of PCSK9 Gene in Patients With Familial Hypercholesterolemia in Russia
    Shakhtshneider, E. V.
    Makarenkova, K. V.
    Astrakova, K. S.
    Ivanoshchuk, D. E.
    Orlov, P. S.
    Ragino, Yu. I.
    Voevoda, M. I.
    KARDIOLOGIYA, 2017, 57 (06) : 46 - 51
  • [23] Use of Targeted Exome Sequencing in Genetic Diagnosis of Chinese Familial Hypercholesterolemia
    Wu, Wen-Feng
    Sun, Li-Yuan
    Pan, Xiao-Dong
    Yang, Shi-Wei
    Wang, Lv-Ya
    PLOS ONE, 2014, 9 (04):
  • [24] Homozygous Familial Hypercholesterolemia in Spain Prevalence and Phenotype-Genotype Relationship
    Sanchez-Hernandez, Rosa M.
    Civeira, Fernando
    Stef, Marianne
    Perez-Calahorra, Sofia
    Almagro, Fatima
    Plana, Nuria
    Novoa, Francisco J.
    Saenz-Aranzubia, Pedro
    Mosquera, Daniel
    Soler, Cristina
    Fuentes, Francisco J.
    Brito-Casillas, Yeray
    Real, Jose T.
    Blanco-Vaca, Francisco
    Ascaso, Juan F.
    Pocovi, Miguel
    CIRCULATION-CARDIOVASCULAR GENETICS, 2016, 9 (06) : 504 - +
  • [25] Alirocumab efficacy in patients with double heterozygous, compound heterozygous, or homozygous familial hypercholesterolemia
    Hartgers, Merel L.
    Defesche, Joep C.
    Langslet, Gisle
    Hopkins, Paul N.
    Kastelein, John J. P.
    Baccara-Dinet, Marie T.
    Seiz, Werner
    Hamon, Sara
    Banerjee, Poulabi
    Stefanutti, Claudia
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (02) : 390 - 396
  • [26] Use of next-generation sequencing to detect LDLR gene copy number variation in familial hypercholesterolemia
    Iacocca, Michael A.
    Wang, Jian
    Dron, Jacqueline S.
    Robinson, John F.
    McIntyre, Adam D.
    Cao, Henian
    Hegele, Robert A.
    JOURNAL OF LIPID RESEARCH, 2017, 58 (11) : 2202 - 2209
  • [27] The doctor's dilemma: Challenges in the diagnosis and care of homozygous familial hypercholesterolemia
    Baum, Seth J.
    Sijbrands, E. J. G.
    Mata, Pedro
    Watts, Gerald F.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2014, 8 (06) : 542 - 549
  • [28] Genetic and Clinical Characteristics of Patients With Homozygous and Compound Heterozygous Familial Hypercholesterolemia From Three Different Populations: Case Series
    Marusic, Tatiana
    Sustar, Ursa
    Sadiq, Fouzia
    Kotori, Vjosa
    Mlinaric, Matej
    Kovac, Jernej
    Shafi, Saeed
    Khan, Iqbal
    Cevc, Matija
    Podkrajsek, Katarina Trebusak
    Battelino, Tadej
    Groselj, Urh
    FRONTIERS IN GENETICS, 2020, 11
  • [29] The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysis
    Leipold, Robert
    Raal, Frederick
    Ishak, Jack
    Hovingh, Kees
    Phillips, Helen
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 (17) : 1843 - 1850
  • [30] Evinacumab for the treatment of homozygous familial hypercholesterolemia
    Gao, Yanli
    Zhang, Baoqi
    Yang, Junyi
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (02) : 139 - 145